SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-013031
Filing Date
2022-05-12
Accepted
2022-05-12 16:10:22
Documents
13
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37641
2 ex99-1.htm EX-99.1 82495
  Complete submission text file 0001493152-22-013031.txt   306088

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eton-20220512.xsd EX-101.SCH 3039
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eton-20220512_lab.xml EX-101.LAB 34476
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eton-20220512_pre.xml EX-101.PRE 22599
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3781
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 22917883
SIC: 2834 Pharmaceutical Preparations